{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T18:06:35Z","timestamp":1776449195565,"version":"3.51.2"},"reference-count":37,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2011,9,14]],"date-time":"2011-09-14T00:00:00Z","timestamp":1315958400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychiatric Ment Health Nurs"],"published-print":{"date-parts":[[2012,6]]},"abstract":"<jats:sec><jats:title>Accessible summary<\/jats:title><jats:p><jats:list list-type=\"explicit-label\">\n<jats:list-item><jats:p>The aim of this audit was to review current practice within a rural mental health service area on the monitoring and documentation of side effects of antipsychotic depot medication. While many aspects of the audit highlighted deficiencies in the monitoring and recording of side effects of depot antipsychotic medication, some other areas of practice revealed encouraging results.<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>The audit highlighted the need for improved clinical documentation and the need for a consistent approach to the assessment of side effects and movement disorders using valid and reliable assessment scales and the need for adequate information for service users and their carers. The need to gain service users' consent has also been highlighted. However, the audit did not address consumer insight into their illness which would impact on the giving of consent and adherence to medication and is worthy of exploration in future audit. In addition, the gap in prescribing and medical reviews requires addressing.<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>A recommendation from the audit is the need to introduce simple checklists. The Glasgow Antipsychotic Side Effects Scale, which takes only 5\u2003min to complete and is available freely in the public domain for use, has been chosen for adoption in the service area. Another simple scale, the Simpson Angus Scale, will also be introduced to assess movement disorders.<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>Collaborative practice with feedback from service users is essential in service improvement and care delivery. This approach will be formally incorporated into future care delivery in the service area.<\/jats:p><\/jats:list-item>\n<\/jats:list><\/jats:p><\/jats:sec><jats:sec><jats:title>Abstract<\/jats:title><jats:p>This audit reviewed current practice within a rural mental health service area on the monitoring and documentation of side effects of antipsychotic depot medication. A sample of 60 case files, care plans and prescriptions were audited, which is 31% of the total number of service users receiving depot injections in the mental health service region (<jats:italic>n<\/jats:italic>= 181). The sample audited had a range of diagnoses, including: schizophrenia, schizoaffective disorder, bipolar affective disorder, depression, alcoholic hallucinosis and autism. The audit results revealed that most service users had an annual documented medical review and a documented prescription. However, only five (8%) case notes examined had documentation recorded describing the condition of the injection site, and alternation of the injection site was recorded in only 28 (47%) case notes. No case notes examined had written consent to commence treatment recorded. In 57 (95%) of case notes, no documentation of recorded information on the depot and on side effects was given. The failure to monitor and record some blood tests was partly attributed to a lack of clarity regarding whose responsibility it was. A standardized checklist has been developed as a result of the audit and this will be introduced by all teams across the service.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1365-2850.2011.01807.x","type":"journal-article","created":{"date-parts":[[2011,9,15]],"date-time":"2011-09-15T07:42:34Z","timestamp":1316072554000},"page":"395-401","source":"Crossref","is-referenced-by-count":9,"title":["Monitoring and documentation of side effects from depot antipsychotic medication: an interdisciplinary audit of practice in a regional mental health service"],"prefix":"10.1111","volume":"19","author":[{"given":"A.","family":"CLEARY","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"WALSH","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"CONNOLLY","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"HAYS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"OLUWOLE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"MACKEN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"DOWLING","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,9,14]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890423363"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v62n1104"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1108\/14664100010361773"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1891\/1559-4343.12.1.44"},{"key":"e_1_2_8_6_1","first-page":"12","article-title":"The future of the mental health system: a survivor perspective","volume":"3","author":"Campbell P.","year":"1996","journal-title":"Mental Health Practice"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-199912030-00002"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.172.1.78"},{"key":"e_1_2_8_9_1","first-page":"8","volume-title":"Progress in Neurology and Psychiatry. Challenging Perceptions of Antipsychotic Long Acting Depot Injections","author":"Gray R.","year":"2007"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1192\/pb.bp.109.027433"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.12968\/bjon.2007.16.9.23433"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0b013e328334e5a8"},{"key":"e_1_2_8_13_1","unstructured":"International Diabetes Federation(2006) Available at:http:\/\/www.idf.org\/webdata\/docs\/IDF_Metadeffinal.pdf(accessed 12 April 2010)."},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2648.1999.01002.x"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2648.2002.02064.x"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.3109\/00207451003760106"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/WNF.0b013e3181a5d08c"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e3181c914b3"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2648.1999.01227.x"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2648.2000.01452.x"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2648.2008.04906.x"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2648.1999.01033.x"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-977X(96)00041-7"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-0979.2000.00181.x"},{"key":"e_1_2_8_25_1","unstructured":"National Institute for Clinical Excellence(2002)Guidance on the use of new atypical antipsychotic drugs for the treatment of schizophrenia. Health Technology Appraisal. No. 43. NICE."},{"key":"e_1_2_8_26_1","unstructured":"NHS Plymouth(2009)Depot antipsychotic medication (including risperidone long acting injection). Policy and practice guidelines for use in adults. Version No. 2.7."},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1192\/apt.11.3.203"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2850.2007.01145.x"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e3181faf0e3"},{"key":"e_1_2_8_30_1","volume-title":"Consensus Statement on High Dose Antipsychotic Medication (CR138)","author":"Royal College of Psychiatrists","year":"2006"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2003.08.044"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1970.tb02066.x"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.3109\/9780203092835"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijo.0801840"},{"key":"e_1_2_8_35_1","unstructured":"United Kingdom Psychiatric Pharmacy Group (UKPPG)(2009)Guidance on the administration to adults of oil\u2010based depot and other long\u2010acting intramuscular antipsychotic injections. Ref incomplete available athttp:\/\/www.ukppg.org.uk\/long\u2010actinginjections\u2010guidelines\u2010sops.html(accessed 12 April 2010)."},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881107087976"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.7748\/ns2005.06.19.40.41.c3891"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1192\/pb.23.1.22"}],"container-title":["Journal of Psychiatric and Mental Health Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2850.2011.01807.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2850.2011.01807.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T14:36:39Z","timestamp":1698676599000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2850.2011.01807.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,14]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["10.1111\/j.1365-2850.2011.01807.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2850.2011.01807.x","archive":["Portico"],"relation":{},"ISSN":["1351-0126","1365-2850"],"issn-type":[{"value":"1351-0126","type":"print"},{"value":"1365-2850","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,14]]}}}